{"url_path":"/sec/nus/8-k/2026-03-27/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 Entry into a Material Definitive Agreement.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-03-27","source_url":"https://www.sec.gov/Archives/edgar/data/1021561/0001140361-26-011757-index.html","accession_number":"0001140361-26-011757","cik":"0001021561","ticker":"NUS","issuer_name":"NU SKIN ENTERPRISES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1021561/0001140361-26-011757-index.html","primary_entity_key":"0001021561","primary_entity_name":"NU SKIN ENTERPRISES, INC."},"word_count":981,"has_tables":true,"body_markdown":"Item 1.01. Entry into a Material Definitive Agreement.\n\nOn March 27, 2026 (the “Closing Date”), Nu Skin Enterprises, Inc. (the “Company”) entered into that certain Second Amendment and Restatement Agreement in connection with\nthe Second Amended and Restated Credit Agreement (the “Credit Agreement”) by and among the Company, as Borrower, the Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent, which amends and restates the Company’s\nexisting amended and restated credit agreement, dated as of June 14, 2022 (as  amended, supplemented or otherwise modified prior to the Closing Date, the “Existing Credit Agreement”). The Credit Agreement provides for a $175 million term loan\nfacility and a $75 million revolving credit facility, each with a term of five years (together, the “Senior Secured Credit Facilities”).  The term loan facility was drawn in full on the Closing Date. The proceeds of the credit facilities are\npermitted to be used for working capital, capital expenditures and other lawful general corporate purposes of the Company. The Company used all proceeds that were drawn on the Closing Date to repay all amounts outstanding under its Existing Credit\nAgreement.\n\nThe revolving credit facility includes a subfacility for swingline loans of up to $10 million, and up to $10 million of the revolving credit facility is available for the\nissuance of letters of credit. The term loan facility will amortize in quarterly installments in amounts resulting in an annual amortization of 10.0% per annum, with the remainder payable at final maturity. The loans under the Credit Agreement bear\ninterest, at the option of the Company, either (i) during any interest period selected by the Company, at the Secured Overnight Financing Rate for deposits in U.S. dollars with a maturity comparable to such interest period, adjusted for statutory\nreserves (“Term SOFR”), plus an initial spread of 1.75% per annum, subject to adjustment based on the consolidated leverage ratio of the Company, or (ii) at the greatest of (x) the federal funds effective rate plus 1/2 of 1%, (y) the prime rate\nfrom time to time announced by Bank of America, N.A. and (z) Term SOFR for a one-month interest period plus 1.00%, plus an initial spread of 0.75% per annum, subject to adjustment based on the consolidated leverage ratio of the Company. If an event\nof default occurs under the Credit Agreement, the interest rate on overdue amounts will increase by 2.00% per annum. The obligations under the Credit Agreement are guaranteed by certain material domestic subsidiaries of the Company (collectively\nwith the Company, the “Loan Parties”) and are secured by a lien on the capital stock of material subsidiaries of the Loan Parties.\n\nThe Credit Agreement requires the Company to maintain a consolidated leverage ratio not exceeding 2.25 to 1.00 and a consolidated interest coverage ratio of no less than\n3.00 to 1.00. The Credit Agreement also includes other covenants, including covenants that, subject to certain exceptions, restrict the ability of the Company and its subsidiaries (i) to create, incur, assume or permit to exist any liens, (ii) to\nincur additional indebtedness, (iii) to make investments and acquisitions, (iv) to enter into mergers, consolidations or similar transactions, (v) to make certain dispositions of assets, (vi) to make dividends, distributions and prepayments of\ncertain indebtedness, (vii) to change the nature of the Company’s business, (viii) to enter into certain transactions with affiliates, (ix) to enter into certain burdensome agreements, (x) to make certain amendments to certain agreements and\norganizational documents and (xi) to make certain accounting changes.\n\nThe Credit Agreement provides for the following events of default: (i) non-payment by any of the Loan Parties of any principal when due or any interest or fees within\nfive Business Days of the due date, (ii) the failure by any Loan Party to comply with any covenant or agreement contained in the Credit Agreement or any other loan document, in certain cases subject to notice and lapse of time, (iii) any\nrepresentation or warranty pursuant to the Credit Agreement or any other loan document is incorrect in any material respect, (iv) a payment default of the greater of $20 million and 12.5% of Consolidated EBITDA or more under other indebtedness of\nany Loan Party or any subsidiary of the Company that continues beyond any applicable grace period or any other event or condition under such indebtedness occurs that results in, or permits the holder thereof to cause such indebtedness to become\nimmediately due and payable, (v) certain bankruptcy or insolvency events with respect to any Loan Party or any material subsidiary, (vi) any attachment or similar process issued or levied against any material property and not released within 60\ndays, (vii) one or more undischarged judgments for the payment of money in an aggregate amount the greater of $20 million and 12.5% of Consolidated EBITDA or more, (viii) certain events relating to ERISA (Employee Retirement Income Security Act)\nplans that could reasonably be expected to result in a material adverse effect, (ix) the invalidity of any material lien or guarantee granted under the loan documents and (x) the occurrence of a change of control. If an event of default occurs and\nis continuing, the Administrative Agent may accelerate the amounts and terminate all commitments outstanding under the Credit Agreement and may exercise remedies in respect of the collateral.\n\nFrom time to time, the Lenders and certain of their affiliates have engaged in, and may in the future engage in, banking and other commercial dealings in the ordinary\ncourse of business with the Company. They have received, or may in the future receive, customary fees and commissions for these transactions.\n\nA copy of the Credit Agreement is attached as Exhibit 10.1 to this Current Report on Form 8-K. Reference is made to the Credit Agreement for its complete terms. The\nforegoing description of the Credit Agreement is qualified in its entirety by reference to such exhibit."}